Prospective Evidence of Concomitant Pancreatic Ductal Adenocarcinoma Risk Among Patients With Branch-duct Intraductal Papillary Mucinous Neoplasms Without Worrisome Features/High-risk Stigmata at Baseline
OBJECTIVE: To evaluate the natural history, especially concomitant pancreatic ductal adenocarcinoma (cPDAC) risk in patients with branch-duct intraductal papillary mucinous neoplasm (BD-IPMN) without worrisome features (WF) or high-risk stigmata (HRS). SUMMARY BACKGROUND DATA: BD-IPMNs without WF/HRS are considered low-risk, yet optimal surveillance strategies remain uncertain. METHODS: In a prospective multicenter Japan Pancreas Society registry, 1234 patients with BD-IPMN without WF/HRS underwent imaging and laboratory surveillance every 6 months for up to 5.17 years. Cumulative incidence, standardized incidence ratios (SIRs), and competing-risk analyses were performed to assess advanced pancreatic neoplasia, defined as IPMN high-grade dysplasia (IPMN-HGD), invasive IPMN, or cPDAC, and associated risk factors. Outcomes were also evaluated under simulated guideline-recommended extended surveillance intervals. RESULTS: During 5.17 years of follow-up, advanced pancreatic neoplasia developed in 26 patients: 10 IPMN-HGD/invasive IPMN and 16 cPDAC. The 5.17-year cumulative incidence was 2.48%; SIRs relative to the general population were 8.01 overall, 3.07 for IPMN-HGD/invasive IPMN, and 4.91 for cPDAC. The cPDAC SIRs were 6.21 and 3.02 for cysts <20 mm and ≥20 mm, respectively. Diabetes history and mural nodule development predicted IPMN-HGD/invasive IPMN, whereas CA19-9 elevation and new or worsening diabetes predicted cPDAC. Of 19 patients eligible for surveillance interval extension, 13 (68%) had a later simulated detection date. CONCLUSION: Patients with BD-IPMN without WF/HRS at baseline had 3.07 and 4.91 times the incidences of IPMN-HGD/invasive IPMN and cPDAC expected in the general population, respectively. Surveillance based solely on cyst stability may warrant caution regarding the timely detection of surgically resectable pancreatic cancer.
Authors
- Nobuhiko Fukuba (ORCID: https://orcid.org/0000-0003-3559-9490)
- Shingo Kozono (ORCID: https://orcid.org/0000-0003-3898-6373)
- Teppei Yoshioka (ORCID: https://orcid.org/0000-0002-3608-0554)
- Hiroyuki Uehara (ORCID: https://orcid.org/0000-0003-4064-0179)
- Teru Kumagi (ORCID: https://orcid.org/0000-0002-2292-7750)
- Shinichi Takano (ORCID: https://orcid.org/0000-0002-3364-828X)
- Daisuke Yamada (ORCID: https://orcid.org/0000-0002-2296-6653)
- Hiroshi Ohyama (ORCID: https://orcid.org/0000-0003-0614-581X)
- Makoto Abue (ORCID: https://orcid.org/0000-0002-1469-6841)
- Reiko E. Yamada (ORCID: https://orcid.org/0000-0002-2680-6972)
- Shinichi Hashimoto (ORCID: https://orcid.org/0000-0002-1223-2349)
- Hiroki Oyama (ORCID: https://orcid.org/0000-0003-3591-821X)
- Masaki Kuwatani (ORCID: https://orcid.org/0000-0002-0265-6068)
- Nao Fujimori (ORCID: https://orcid.org/0000-0003-4286-8804)
- Toru Maruo (ORCID: https://orcid.org/0009-0001-2844-7838)
- Toshifumi Kin (ORCID: https://orcid.org/0000-0003-1349-8154)
- Noboru Ideno (ORCID: https://orcid.org/0000-0003-4745-8417)
- Yoshihiro Nishikawa (ORCID: https://orcid.org/0000-0002-1113-6937)
- Koji Yamakoshi
- Hiroya Terabe
- Shinsuke Koshita (ORCID: https://orcid.org/0000-0001-6880-5532)
- Nobuo Toda (ORCID: https://orcid.org/0000-0001-5426-1896)
- Yoshio Sogame (ORCID: https://orcid.org/0000-0001-6919-5625)
- Keiji Hanada (ORCID: https://orcid.org/0000-0003-3196-8551)
- Toyoma Kaku (ORCID: https://orcid.org/0000-0003-4461-9203)
- Hiroyuki Maguchi (ORCID: https://orcid.org/0000-0001-6807-5613)
- Fuyuhiko Motoi (ORCID: https://orcid.org/0000-0001-7601-8395)
- Atsushi Masamune (ORCID: https://orcid.org/0000-0001-7184-7282)
- Kazuo Hara (ORCID: https://orcid.org/0000-0002-4699-6136)
- Toshiyasu Shiratori
- Yousuke Nakai (ORCID: https://orcid.org/0000-0001-7411-1385)
- Tsukasa Ikeura (ORCID: https://orcid.org/0000-0002-0241-2821)
- Motohiro Yoshinari (ORCID: https://orcid.org/0000-0003-4478-8664)
- Tetsuya Takikawa (ORCID: https://orcid.org/0000-0002-6214-7337)
- Mamoru Takenaka (ORCID: https://orcid.org/0000-0001-7308-4311)
- Takao Ohtsuka (ORCID: https://orcid.org/0000-0002-2946-1092)
- Kasen Kobashikawa
- Takahiro Anami
- Yoshifumi Fujimoto
- Yasutaka Ishii (ORCID: https://orcid.org/0000-0003-3545-8743)
- Akitoshi Kobayashi
- Yoshinari Furukawa
- Manabu Kawai (ORCID: https://orcid.org/0000-0001-5987-7614)
- Shinya Uemura (ORCID: https://orcid.org/0000-0002-3283-1680)
- Satoshi Tanno (ORCID: https://orcid.org/0009-0008-0593-1273)
- Yasuhisa Mori (ORCID: https://orcid.org/0000-0001-9928-3933)
- Kentaro Sudo
- Junya Gibo
- Kosuke Okuwaki
- Yukiko Ito
- Masafumi Nakamura
- Masao Tanaka
- Shoji Tokunaga
- Kazuyuki Matsumoto
Institutions
- Kurume University (JP)
- Kagoshima University (JP)
- Yamagata University (JP)
- Hiroshima University (JP)
- Kansai Medical University (JP)
- Kyushu University (JP)
- Chiba University (JP)
- Shimane University (JP)
- University of Occupational and Environmental Health Japan (JP)
- Wakayama Medical University (JP)
- Tohoku University (JP)
- Kyoto University (JP)
- National Kyushu Medical Center (JP)
- Fukuoka University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Kurume University Hospital (JP)
- Okayama University Hospital (JP)
- Hiroshima General Hospital (JP)
- Japanese Red Cross Medical Center (JP)
- Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital (JP)
- Gifu University Hospital (JP)
- Miyagi Prefectural Hospital Organization (JP)
- Yodogawa Christian Hospital (JP)
- Ehime University Hospital (JP)
- Kitasato University Hospital (JP)
- Shimonoseki City Hospital (JP)
- Kameda Medical Center (JP)
- Chiba Cancer Center (JP)
- Sendai Medical Center (JP)
- Mie University Hospital (JP)
- Kyushu Hospital (JP)
- Okinawa Prefectural Chubu Hospital (JP)
- Kitakyushu Municipal Medical Center (JP)
- Mitsui Memorial Hospital (JP)
- Funabashi Municipal Medical Center (JP)
- Aichi Cancer Center (JP)
- Tokyo Women's Medical University (JP)
- Teine Keijinkai Hospital (JP)
- Hokkaido University Hospital (JP)
- Aso Iizuka Hospital (JP)
- Kyoto University Hospital (JP)
- Osaka International Cancer Institute (JP)
- Onomichi General Hospital (JP)
- Ehime University (JP)
- Urasoe General Hospital (JP)
- Sendai City Medical Center (JP)
- Institute of Gastroenterology, Tokyo Women's Medical University (JP)
- Aichi Cancer Center Hospital (JP)
- Kitasato University (JP)
- University of Yamanashi (JP)
- The University of Tokyo (JP)
- Wakayama University (JP)
- Kindai University (JP)
- Kumamoto University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/sla.0000000000007255
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00